Oura Inc. prepares for a $15.6 billion Nasdaq IPO, supported by major underwriters Goldman Sachs, Morgan Stanley, and JPMorgan, despite facing a class-action lawsuit regarding product accuracy.
Oura Inc. is conducting a $15.6B IPO on Nasdaq with strong institutional backing despite an ongoing class-action lawsuit regarding product accuracy.
Goldman Sachs is leading the underwriting group for the Oura IPO, generating fee revenue from the transaction.
Morgan Stanley is part of the underwriting syndicate for the Oura IPO, contributing to deal execution fees.
JPMorgan is listed as a lead underwriter for the Oura IPO, participating in the distribution of shares.
Eli Lilly and Company is indicated as an investor in the Oura IPO, representing a minor strategic investment rather than a core operational driver.
Smart-ring manufacturer Oura Inc. is set to launch its initial public offering on the Nasdaq, aiming for a valuation of $15.62 billion. The company plans to raise up to $2.2 billion, with significant backing from institutional investors including Eli Lilly and Dragoneer Investment Group.
Oura is currently defending itself against a class-action lawsuit alleging that the company misled consumers regarding the accuracy of its sleep-tracking measurements.